Get started
Author

Valentina De Pascale

Observed names: DE PASCALE, VALENTINA, De Pascale, Valentina, V. De Pascale, Valentina De Pascale
ORCID: 0000-0003-1015-8867
Observed ORCID: 0000-0003-1015-8867
OpenAlex ID: A5036100188
CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer
2025 · Alina Catalina Palcau, Claudio Pulito, et al. · Journal of Experimental & Clinical Cancer Research · 24
It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA : Systematic review and meta‐analysis
2023 · Francesca Paolini, Flaminia Campo, et al. · Head & Neck · 23
PDF
Detection of anti-SARS CoV-2 antibodies in human serum by means of Bloch surface waves on 1D photonic crystal biochips
2023 · Agostino Occhicone, Alberto Sinibaldi, et al. · Biosensors and Bioelectronics X · 16
Circulating tumor HPV DNA in the management of HPV + oropharyngeal cancer and its correlation with MRI
2024 · Flaminia Campo, Francesca Paolini, et al. · Head & Neck · 15
PDF
Circulating HPVDNA in patients undergoing transoral robotic surgery for oropharyngeal cancer: liquid biopsy could identify molecular residual disease
2025 · Flaminia Campo, Francesca Paolini, et al. · European Archives of Oto-Rhino-Laryngology · 11
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma
2025 · Alex De Gregorio, Andrea Sacconi, et al. · Journal of Translational Medicine · 10
PDF
Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy
2025 · Tiziana Bruno, Maria Chiara Cappelletto, et al. · Blood · 6
PDF
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma
2025 · Claudio Pulito, Sebastiano Vaccarella, et al. · Drug Resistance Updates · 5
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Carlotta Frascolla, Riccardo Mastroianni, et al. · Journal of Experimental & Clinical Cancer Research · 4
Dissecting endometrial cancer complexity in response to standard and targeted therapies
2025 · Sebastiano Vaccarella, Valentina Bruno, et al. · Cell Death and Disease · 4
PDF
Correction: Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer
2024 · Federica Ganci, Matteo Allegretti, et al. · Biomarker Research · 4
PDF
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer
2025 · Matteo Allegretti, David J. Joun, et al. · Journal of Experimental & Clinical Cancer Research · 1
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening.
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Open Access CRIS of the University of Bern
Additional file 3 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 6 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 2 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 4 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 8 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 5 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 7 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Additional file 1 of Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening
2026 · Frascolla, Carlotta, Mastroianni, Riccardo, et al. · Figshare
Lymph node micrometastases in OSCC: molecular profiling of histologically negative lymph nodes for prognostic and therapeutic purposes
2026 · DE PASCALE, VALENTINA · IRIS Research product catalog (Sapienza University of Rome)
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer
2026 · Allegretti, Matteo, Joun, David J., et al. · Figshare
6P Organoid models reveal endometrial cancer microenvironment and drug resistance
2025 · S. Vaccarella, V. Bruno, et al. · ESMO Open
PDF
Works count: 42
Citation count: 123
H-index: 6
I10-index: 6
Year
Topic
Type